While all the mature lymphoid neoplasms show an improvement over time, no clear increase is observed for the myeloid neoplasms: AML, MDS, MDS/MPN, and BCR::ABL1-negative MPN (PV, ET, PMF), with the exception of CML. This evidence concerns the gene ABL1 and lymphoid neoplasm.